Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep159 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Pharmacogenetics of metformin in polycystic ovary syndrome and type 2 diabetes mellitus

Strasser Moritz , Schweighofer Natascha , Obermayer Anna , Borzan Valentin , Haudum Christoph , Lerchbaum Elisabeth , Trummer Christian , Dimai Hans , Sourij Caren , Sourij Harald , Pieber Thomas , Obermayer-Pietsch Barbara

BackgroundMetformin is a widely used and effective agent in type 2 diabetes mellitus (T2DM) and polycystic ovary syndrome (PCOS). Yet, the mechanisms of action and the occurrence of side effects (e.g. abdominal bloating and pain), are still poorly understood. Since organic cation transporters (OCTs) are responsible for the hepatic and renal transport of metformin, we investigated a series of short nucleotide polymorphisms (SNPs) in the OCT genes in PCOS ...